Frankfurt - Delayed Quote EUR

IRLAB Therapeutics AB (6IRA.F)

0.6530
-0.0280
(-4.11%)
At close: May 16 at 8:06:15 AM GMT+2
Loading Chart for 6IRA.F
  • Previous Close 0.6810
  • Open 0.6530
  • Bid 0.6440 x --
  • Ask 0.6690 x --
  • Day's Range 0.6530 - 0.6530
  • 52 Week Range 0.3560 - 1.4600
  • Volume 3,200
  • Avg. Volume 55
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 6IRA.F

View More

Performance Overview: 6IRA.F

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

6IRA.F
29.48%
OMX Stockholm 30 Index (^OMX)
2.45%

1-Year Return

6IRA.F
50.90%
OMX Stockholm 30 Index (^OMX)
2.48%

3-Year Return

6IRA.F
80.15%
OMX Stockholm 30 Index (^OMX)
26.92%

5-Year Return

6IRA.F
84.47%
OMX Stockholm 30 Index (^OMX)
70.33%

Compare To: 6IRA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 6IRA.F

View More

Valuation Measures

As of 5/15/2025
  • Market Cap

    34.47M

  • Enterprise Value

    32.44M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.89

  • Price/Book (mrq)

    83.19

  • Enterprise Value/Revenue

    3.58

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 6IRA.F

View More